Responsiveness to psychological stress in females
=================================================

Adverse responsiveness to psychological stress is a major health hazard, which is more prevalent in women than in men ([@B01]). The female brain, unlike its male counterpart, operates in a changing chemical milieu caused by cyclical changes in production of female sex hormones in the periphery during the menstrual cycle (estrous cycle in animals). Many of these compounds are neuroactive and their lipophilic nature enables them to pass readily through the blood brain barrier and produce significant influences on brain function through actions at both membrane-bound and nuclear receptors ([@B02]). In large numbers of women, the late luteal phase of the menstrual cycle is characterised by the development of premenstrual syndrome (PMS): a constellation of adverse psychological symptoms that include worsening of mood and episodes of aggressive behaviour, often triggered by relatively minor stressors related to everyday life ([@B03]). PMS and its more severe counterpart premenstrual dysphoric disorder (PMDD) interferes significantly with the woman\'s quality of life, impairing work, family relationships and other social activities. Interestingly, PMS does not occur in anovulatory cycles ([@B04],[@B05]), suggesting that cyclical changes in sex hormones, rather than absolute levels may be the trigger for the syndrome. The late luteal phase of the menstrual cycle is characterised by a rapid decline in secretion of the sex hormones progesterone and estrogen, suggesting that one or both of these hormones may be linked to the development of symptoms. This article will focus on the recent evidence obtained in rodents that indicates that the fall in progesterone secretion, which occurs during the late diestrous phase in rats, leads to a change in gamma-aminobutyric acid (GABA~A~) receptor expression in the brain that is manifested behaviourally as enhanced responsiveness of the animal to mild anxiogenic stress. A consideration of the effect of estrogen on brain function and behaviour is beyond the scope of this article and has recently been reviewed elsewhere ([@B06]).

Responsiveness to stress varies during the estrous cycle in rodents
===================================================================

Female rodents, like women, show estrous cycle-linked changes in responsiveness to stressful situations. In general, higher levels of anxiety and responsiveness to mild anxiogenic stress have been reported in the non-receptive phase of the cycle (diestrus) compared to the receptive phase (proestrus and estrus) in both rats and mice ([@B07]-[@B13], but see Ref. [@B14] for an opposite view). Unlike women in whom the late luteal (premenstrual) phase is characterised by falling levels of both estrogen and progesterone, the latter part of diestrus in rats, when responsiveness to stress is increased, is associated with a rapid fall only in plasma concentration of progesterone, whilst estrogen secretion remains at a stable low level ([@B15]). Since progesterone passes the blood brain barrier readily, fluctuations in peripheral secretion will be reflected in the brain. Falling concentration of progesterone in the brain could therefore be the key factor that triggers increased responsiveness to acute stress during late diestrus in rats and, by analogy, during the late luteal phase in women. In support of this idea, behavioural changes similar to those seen in late diestrus can be induced in rats by withdrawal from longterm dosing with exogenous progesterone ([@B16]-[@B19]). The behaviour of spontaneously cycling rats in late diestrus therefore appears to offer a useful model in which to study the role of progesterone in the development of premenstrual syndrome in women.

Falling progesterone leads to changes in neuronal excitability
==============================================================

There are several indications that rapid fluctuations in endogenous steroid concentrations result in altered GABA~A~ receptor kinetics, which impacts on neuronal excitability. In rats, withdrawal from progesterone, either during the late diestrus phase in cycling animals or following an exogenous progesterone withdrawal dosing regimen, has been shown to evoke up-regulation of α4, β1 and δ subunits of the GABA~A~ receptor in several brain structures ([@B07],[@B19]-[@B23]). The effect was due not to progesterone itself but to the fall in concentration of its neuroactive metabolite allopregnanolone (ALLO), which triggers enhanced transcription of the genes encoding α4, β1 and δ subunits of the GABA~A~ receptor ([@B16],[@B17],[@B23]). Alpha4, β1 and δ subunits are able to assemble into functional receptors. Recombinant α4β1δ GABA~A~ receptors show electrophysiological properties characteristic of other extrasynaptic receptors containing δ subunits. Typically, these act tonically to modify the level of ongoing GABAergic inhibitory activity that regulates the excitability of neuronal ensembles ([@B22],[@B24]-[@B26]).

Functional consequences of progesterone withdrawal
==================================================

There is now compelling evidence that a reduction in brain concentration of progesterone enhances stress-induced anxiety-linked behaviours. Whether induced experimentally by withdrawal from an exogenous progesterone dosing regimen ([@B17],[@B22],[@B23],[@B27],[@B28]) or occurring naturally as a response to natural fluctuations during the estrous cycle ([@B10]-[@B12],[@B18]), falling progesterone is anxiogenic in a variety of behavioural tests.

The periaqueductal gray matter (PAG) is a midbrain region recognised as key to mediating behavioural and autonomic components of responses to stressful challenge. As such, it has the potential to provide a useful brain locus for investigating the mechanisms underlying female hormone-induced links between transcriptional changes at the receptor level and changes in neuronal excitability and behaviour. As with other brain regions, the vast majority of studies on this region have been carried out in males. However, as the results from more studies on females begin to emerge, it is becoming clear not only that the PAG is involved in processing stress-evoked behaviour in the female sex, as in males, but also that the excitability of its circuitry fluctuates during the estrous cycle. In females in late diestrus, the fall in brain concentration of progesterone, and hence ALLO, that occurs during this stage, triggers up-regulation of extrasynaptic α4βδ GABA~A~ receptor expression in the PAG, which is confined principally to the GABAergic neuronal subpopulation ([Figure 1](#f01){ref-type="fig"}). This transcriptional change correlates with an increase in functional excitability of the intrinsic PAG circuitry that translates in the conscious animal to raised anxiety levels and increased behavioural responsiveness to acute psychogenic stress ([Figure 2A](#f02){ref-type="fig"}). At the cellular level electrophysiological studies in spontaneously cycling rats *in vivo* have demonstrated that GABAergic tone on output neurons within the PAG is reduced during the late diestrous phase ([@B29]), which renders the circuitry intrinsically more excitable. Direct evidence for an increase in functional excitability of the PAG circuitry during late diestrus has been provided by the recent report of a lowered threshold for escape behaviour evoked by direct electrical stimulation in the PAG in late diestrus ([@B30]). Autonomic responsiveness to a pentagastrin, a panicogenic agent known to activate PAG circuitry following systemic administration, was also increased during the late diestrous phase ([@B31]). At this time, functional activation of PAG circuitry evoked by acute exposure to a mild anxiogenic stress is also changed, as reflected by decreased regional expression of the immediate early gene *c-fos* (32 and [Figure 2B](#f02){ref-type="fig"}). At the present time the phenotype of the Fos-positive population in the PAG has not been determined. However, the findings are consistent with a stress-induced decreased *c-fos* expression in the GABAergic population, and at the same time with an increase in *c-fos* expression in PAG output neurons, which are likely to be less numerous than the GABAergic population.

Figure 1.Schematic drawing showing the functional consequences of increased α4β1δ GABA~A~ receptor expression in the periaqueductal gray matter (PAG). *A*, When expression of α4β1δ receptors is low, spontaneous activity in GABAergic interneurones in the PAG limits the excitability of the output neurones. *B*, Increased expression of α4β1δ receptors when progesterone levels fall in late diestrous leads to an increase in tonic current carried by GABAergic cells, which limits their ongoing activity. The output neurones therefore become intrinsically more excitable, and the threshold for activation by stressful stimuli is lowered. Reproduced from Ref. [@B41] with permission.

Figure 2.*A*, Change in latency of the tail flick reflex (s) following exposure to 5-min anxiogenic vibration stress in rats at different stages of the estrous cycle. Data (mean ± SEM) are reported as change in tail flick latency (TFL) from baseline in 6-min post-vibration stress. *B*, Density of Fos-positive neurons in the periaqueductal gray matter (PAG) of rats exposed to anxiogenic stress and tail flick testing at different stages of the estrous cycle. P = proestrus; E = estrus; ED = early diestrus; LD = late diestrus. Figure drawn from data in Ref. [@B32] and reproduced with permission. ^\*^P \< 0.05, ^\*\*^P \< 0.01 (*post hoc* Bonferroni test) stressed group compared to the non-stressed group after significant (P \< 0.05) one-way ANOVA. §§P \< 0.01 LD stressed group compared to stressed rats at all other stages of the estrous cycle (*post hoc* Bonferroni test).

Interestingly, in hippocampal tissue withdrawal from progesterone evoked an increased α4 receptor expression in the hippocampus and a reduction in total GABA-stimulated current measured in dissociated pyramidal neurons ([@B17],[@B33]). No effects were observed in cortex or cerebellum. Thus, there may be regional differences with respect to the effects triggered by withdrawal from progesterone. Moreover, at the cellular level the functional outcome of receptor upregulation appears to be dependent on the cell type that expresses α4 subunit-containing GABA~A~ receptors, e.g., interneurons or principal neurons.

The kinetics of progesterone withdrawal determines its anxiogenic effect
========================================================================

It is becoming clear that withdrawal from progesterone during the late diestrous phase induces a rebound hyperexcitable state manifested by significant changes in responsiveness to anxiogenic stress. Interestingly, the critical event for inducing this effect may be related to the kinetics of the decline in steroid levels rather than the absolute magnitude of the fall. In a study on female rats chronically treated with estrogen and progesterone, a rapid withdrawal of these hormones precipitated increased startle and anxiety-like behaviour, which was not seen if the hormone levels were allowed to decline gradually ([@B34],[@B35]). Since similar increases in anxiety behaviour can be precipitated by abrupt withdrawal from progesterone alone ([@B16]-[@B18]), the trigger for anxiogenesis in the former study is likely to be the rapid decline in concentration in the brain of progesterone, and hence its neuroactive metabolite ALLO. Measures to produce a more gradually tapered fall in progesterone levels might therefore be effective in preventing the withdrawal effect.

Neurosteroid replacement in late diestrus prevents the development of stress-induced hyperalgesia
=================================================================================================

We hypothesized that short-term neurosteroid replacement, timed to blunt the rate of the natural fall in ALLO that occurs during the late diestrous phase in spontaneously cycling rats, should prevent the increased responsiveness to stress that normally occurs at this time ([Figure 3](#f03){ref-type="fig"}). In males the selective serotonin reuptake inhibitor (SSRI) fluoxetine has been shown to produce rapid onset steroidogenic effects following acute administration, by raising plasma and brain concentrations of ALLO ([@B36]-[@B38]). Importantly, these effects could be induced at doses below the threshold for effects on 5-hydroxytryptamine (5-HT) systems ([@B37]). We have shown that short-term administration of a low dose of fluoxetine (1.75 mg/kg, *ip*) was also steroidogenic in females, producing a doubling of whole brain ALLO concentration ([@B39]).

Figure 3.Schematic presentation of the rationale behind short-term neurosteroid replacement to prevent development of progesterone withdrawal-evoked anxiogenesis during late diestrus. *A*, At late diestrus, the fall in brain concentration of progesterone and its neuroactive metabolite allopregnanolone (ALLO) triggers a withdrawal syndrome manifested as an increased responsiveness to stress. *B*, Short-term dosing with a steroidogenic agent in the evening of early diestrus should raise plasma and hence brain allopregnanolone transiently and so blunt the rapid fall in allopregnanolone that normally occurs during late diestrus. The trigger for development of the withdrawal syndrome should be removed.

Compared to other cycle stages, rats in late diestrus normally show an exaggerated response to anxiogenic vibration stress, which is manifested as hyperalgesia ([@B18]). Administering low-dose fluoxetine to female rats on the evening of early diestrus, with a top up next morning when they had reached late diestrus, completely prevented the development of stress-induced hyperalgesia ([Figure 4A](#f04){ref-type="fig"}). Similarly, the functional deactivation within the PAG that is normally induced by exposure to the vibration stress in late diestrus was prevented as well ([Figure 4B](#f04){ref-type="fig"}). Importantly, the behavioural effects of fluoxetine could be reproduced following dosing with ganaxolone (data not shown), a synthetic analogue of ALLO not reported to have effects on 5-HT systems ([@B40]). Thus, the effect of fluoxetine is likely to be due to its steroidogenic action. The dramatic effects of short-term neurosteroid replacement in preventing the appearance of estrous cycle-linked anxiogenesis in rats may have relevance to the quest for more effective treatments of menstrual cycle-linked dysphoria in women.

Figure 4.*A*, Short-term dosing with fluoxetine (1.75 mg/kg) on the evening of late diestrus, with a top up on the morning of late diestrus, prevents the development of stress-induced hyperalgesia during late diestrus (decrease in tail flick latency (TFL) compared to naive non-stressed rats). White bars = non-stressed rats; light gray bars = stressed vehicle-treated rats; dark gray bars = stressed fluoxetine-treated rats. *B*, Fluoxetine administration also prevented the reduction in stress-induced functional deactivation in the periaqueductal gray matter (PAG) (decrease in density of Fos-positive neurons in the PAG compared to naive non-stressed rats; Devall AJ and Lovick TA, unpublished results). ^\*^P \< 0.05 compared to vehicle-treated rats in late diestrus (oneway ANOVA followed by the Bonferroni test).

In conclusion, the data summarized here show how cyclical changes in production of progesterone during the estrous cycle can have a powerful effect on functioning of the female brain. In rodents, this occurs over a remarkably short time frame. The withdrawal effects evoked by the natural cyclical variation in secretion of progesterone during the estrous cycle occur over 12- to 24-h periods, influencing anxiety levels and responsiveness to anxiogenic stress. To date the overwhelming majority of the studies on brain function and behaviour in animals has been confined to males, a common argument for the single sex approach being that data obtained from females are more variable and may be confounded by hormonal influences. Increasingly, however, it is being recognized that sex differences do exist, both in terms of behaviour and responsiveness to certain drugs. It is essential that the effects of possible influences of the ovarian cycle on brain function and behaviour are incorporated into experimental designs in future studies using females. In a world in which 50% of the population is female, such differences are important and should no longer be overlooked.

[^1]: Presented at the III Fórum em Neurobiologia do Estresse, Araraquara, SP, Brazil, September 8-10, 2011.
